CorMedix (CRMD) vs Ironwood Pharmaceuticals (IRWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Ironwood Pharmaceuticals (IRWD) has outperformed CorMedix (CRMD) over the past year, gaining 146.7% versus a loss of 34.4%. Over five years, CRMD leads with a +47.1% price change compared with -72.5% for IRWD. Ironwood Pharmaceuticals is the larger company by market cap ($619.6 million vs $567.4 million), about 1.1 times the size.
On valuation, Ironwood Pharmaceuticals trades at a lower forward P/E (2.5x vs 20.8x for CorMedix).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRMD | IRWD |
|---|---|---|
| Share price | $7.28 | $3.75 |
| Market cap | $567.43M | $619.65M |
| 1-day change | 0.00% | +3.31% |
| YTD return | -37.40% | +11.28% |
| 1-year return | -34.36% | +146.71% |
| 5-year return | +47.07% | -72.55% |
| P/E ratio (TTM) | 3.55 | 4.87 |
| Forward P/E | 20.80 | 2.50 |
| EPS (TTM) | $2.05 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.02 | $5.78 |
| 52-week low | $6.13 | $1.41 |
| Distance from 52-week high | -44.09% | -35.12% |
| Average volume | 1.06M | 2.08M |
| Shares outstanding | 77.94M | 165.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRWD has outperformed CRMD by 181.1 percentage points over the past year.
- Ironwood Pharmaceuticals trades at a higher earnings multiple (4.9x vs 3.6x trailing P/E).
CRMD vs IRWD FAQ
Which is bigger, CorMedix or Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals (IRWD) is larger, with a market capitalization of $619.65M compared with $567.43M for CorMedix (CRMD).
Which stock has performed better over the past year, CRMD or IRWD?
IRWD returned +146.71% over the past 12 months, compared with -34.36% for CRMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CRMD or IRWD?
CRMD has the lower trailing P/E at 3.6, versus 4.9 for IRWD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are CorMedix and Ironwood Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.